Literature DB >> 2794045

Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.

A W van den Wall Bake1, W E Beyer, J H Evers-Schouten, J Hermans, M R Daha, N Masurel, L A van Es.   

Abstract

Primary IgA nephropathy (IgAN) is characterized by mesangial deposits of IgA1, increased serum IgA1 levels, and circulating immune complexes containing predominantly IgA1. It has previously been found that patients with IgAN have a higher than normal IgA response to vaccination, but the IgA subclasses have not been studied. To investigate whether the IgA hyperresponsiveness is limited to the subclass IgA1, which is involved in the pathogenesis of IgAN, we compared the immune responses of 18 patients with 22 healthy controls after intramuscular vaccination with inactivated influenza virus. Antibody titers were significantly higher (P less than 0.0001) for the IgA1 subclass in patients versus controls, but not for the other isotypes. A substantial portion of the IgA and IgA1 antiinfluenza immune response comprised polymers in both patients and controls. There was no preferential response of polymers in patients. Patients produced significantly more monomeric IgA1 antibodies than controls. These results show that patients with IgAN have a hyperresponsiveness limited to the subclass IgA1 and mainly expressed by an excess of monomers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794045      PMCID: PMC329762          DOI: 10.1172/JCI114269

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  A polymeric IgA response in serum can be produced by parenteral immunization.

Authors:  F Mascart-Lemone; J Duchateau; M E Conley; D L Delacroix
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

2.  Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.

Authors:  C Lue; A Tarkowski; J Mestecky
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

Review 3.  Interleukin 5, a mucosal lymphokine?

Authors:  G R Harriman; W Strober
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

Review 4.  The commonest glomerulonephritis in the world: IgA nephropathy.

Authors:  G D'Amico
Journal:  Q J Med       Date:  1987-09

5.  Polymeric IgA antibody response to rabbit antithymocyte globulin in renal transplant recipients.

Authors:  P S Hiemstra; W M Baldwin; E A van der Voort; L C Paul; L A van Es; M R Daha
Journal:  Transplantation       Date:  1988-04       Impact factor: 4.939

6.  Tonsillar distribution of IgA and IgG immunocytes and production of IgA subclasses and J chain in tonsillitis vary with the presence or absence of IgA nephropathy.

Authors:  J Nagy; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1988-04       Impact factor: 3.487

7.  Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis.

Authors:  F O Mascart-Lemone; J R Duchateau; J Oosterom; J P Butzler; D L Delacroix
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

8.  Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression.

Authors:  P D Murray; D T McKenzie; S L Swain; M F Kagnoff
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

9.  Humoral immune response in patients with IgA and IgM glomerulonephritis.

Authors:  A Pasternack; J Mustonen; P Leinikki
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

10.  The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy.

Authors:  A W van den Wall Bake; M R Daha; J Radl; J J Haaijman; A Van der Ark; R M Valentijn; L A Van Es
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

View more
  26 in total

1.  Expression of T cell receptor variable region families by bone marrow gammadelta T cells in patients with IgA nephropathy.

Authors:  K S Buck; E M Foster; D Watson; J Barratt; I Z A Pawluczyk; J F Knight; J Feehally; A C Allen
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  For further investigations in IgA nephropathy the approach from phenotype to genotype is welcome.

Authors:  F P Schena
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.

Authors:  L Layward; A C Allen; S J Harper; J M Hattersley; J Feehally
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

4.  Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy.

Authors:  J W De Fijter; M R Daha; W E Schroeijers; L A van Es; C Van Kooten
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 5.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

6.  Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.

Authors:  J W Eijgenraam; B D Oortwijn; S W A Kamerling; J W de Fijter; A W L van den Wall Bake; M R Daha; C van Kooten
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 7.  Molecular heterogeneity of human IgA antibodies during an immune response.

Authors:  M W Russell; C Lue; A W van den Wall Bake; Z Moldoveanu; J Mestecky
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

8.  Low antibody affinity restricted to the IgA isotype in IgA nephropathy.

Authors:  L Layward; A C Allen; J M Hattersley; S J Harper; J Feehally
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

9.  Development of a model of early-onset IgA nephropathy.

Authors:  Keiko Okazaki; Yusuke Suzuki; Mareki Otsuji; Hitoshi Suzuki; Masao Kihara; Tadahiro Kajiyama; Azusa Hashimoto; Hiroyuki Nishimura; Rhubell Brown; Stacy Hall; Jan Novak; Shozo Izui; Sachiko Hirose; Yasuhiko Tomino
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

Review 10.  Pathogenesis of idiopathic IgA nephropathy.

Authors:  D G Williams
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.